In this third and final segment in DAIC’s “One on One” series with Dr. Christine Seidman, learn what’s on the horizon at Harvard’s Seidman Lab, and how she views the value of learning from and mentoring a new generation of researchers.  Part 1 in this 3-part series delved into the research and treatments of the heart muscle disorder, hypertropic cardiomyopathy. You can view VIDEO, Part 1: Hypertrophic Cardiomyopathy: One on One with a Cardiovascular Research Leader, here. In Part 2 of this series with Dr. Christine Seidman, a discussion on the discovery of gene-based diagnostics at Harvard’s Seidman Lab which allowed for targeted disease treatment of hypertrophic cardiomyopathy. You can watch Part 2: Hypertrophic Cardiomyopathy in Focus, here. Related Hypertrophic Cardiomyopathy content: Part 1: Hypertrophic Cardiomyopathy: One on One with a Cardiovascular Research Leader Part 2: Hypertrophic Cardiomyopathy in Focus Imbria Pharmaceuticals Completes Enrollment in the Phase 2 IMPROVE-ISC